These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3078574)

  • 21. Protective effect of a selective leukotriene antagonist in endotoxemia in the rat.
    Cook JA; Wise WC; Halushka PV
    J Pharmacol Exp Ther; 1985 Nov; 235(2):470-4. PubMed ID: 2997435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis.
    Altavilla D; Squadrito F; Canale P; Ioculano M; Squadrito G; Campo GM; Serranò M; Sardella A; Urna G; Spignoli G
    Eur J Pharmacol; 1995 Nov; 286(1):31-9. PubMed ID: 8566149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
    Arner M; Högestätt ED; Uski TK
    Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of leukotriene receptor antagonists on vascular permeability during endotoxic shock.
    Cook JA; Li EJ; Spicer KM; Wise WC; Halushka PV
    Circ Shock; 1990 Nov; 32(3):209-18. PubMed ID: 2175680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
    Bitterman H; Yanagisawa A; Lefer AM
    Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of drugs that selectively inhibit thromboxane synthesis to modify endotoxin shock in conscious rats.
    Furman BL; McKechnie K; Parratt JR
    Br J Pharmacol; 1984 May; 82(1):289-94. PubMed ID: 6375795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboxane-mimetic U46619 causes depressor responses in anaesthetized rats.
    Hui SG; Ogle CW
    J Pharm Pharmacol; 1991 Aug; 43(8):592-3. PubMed ID: 1681077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosis.
    Thiemermann C; Ney P; Schrör K
    Eur J Pharmacol; 1988 Oct; 155(1-2):57-67. PubMed ID: 2977337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of daltroban, a thromboxane (TX) A2 receptor antagonist, on lipid metabolism and atherosclerosis.
    Pill J; Metz J; Stegmeier K; Hartig F
    Agents Actions Suppl; 1992; 37():107-13. PubMed ID: 1632287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
    Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of H1 and H2 histamine receptor antagonists on the development of endotoxemia in the conscious, unrestrained rat.
    Brackett DJ; Schaefer CF; Wilson MF
    Circ Shock; 1985; 16(2):141-53. PubMed ID: 2414028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exchange transfusions in rats with a perfluorated blood substitute: effect on thromboxane B2 levels during endotoxemia.
    Cook JA; Wise WC; Tempel GE; Halushka PV
    Circ Shock; 1985; 15(3):193-204. PubMed ID: 3978769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The strong contractile effect of the thromboxane receptor agonist U-46619 in isolated human pulmonary arteries and its competitive antagonism by BM-13.505.
    Sjöberg T; Steen S
    Acta Physiol Scand; 1989 Jun; 136(2):161-5. PubMed ID: 2528885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
    Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
    Aoki N; Lefer AM
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of endogenous thromboxane synthesis by exogenous prostacyclin during endotoxemia in conscious sheep.
    Flynn JT; Demling RH
    Adv Shock Res; 1982; 7():199-207. PubMed ID: 6753534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bay U 3405 inhibits cerebral vasospasm induced by authentic thromboxane A2.
    Braun M; Schrör K
    Stroke; 1990 Dec; 21(12 Suppl):IV152-4. PubMed ID: 2260141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
    Schumacher WA; Heran CL; Ogletree ML
    Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular and pulmonary effects of human recombinant tumor necrosis factor in the conscious rat.
    Turner CR; Esser KM; Wheeldon EB; Slivjak M; Smith EF
    Circ Shock; 1989 Aug; 28(4):369-84. PubMed ID: 2673572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of the protective action of Bay-u-3405, a new specific thromboxane receptor antagonist, in arachidonate-induced sudden death.
    Ma XL; Karasawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):105-10. PubMed ID: 1906568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.